Terms ending in 2033
Every in-force patent on Amgen Inc.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,511,189 | Insertion Mechanism for a Drug Delivery Pump In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 10,537,682 | Injector and Method of Assembly In force · High confidence | Amgen Inc. | In force | High confidence | |
| US D808,010 | Injection Device In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 10,336,798 | Growth Differentiation Factor 15 (GDF-15) Polypeptides In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 11,739,131 | Growth Differentiation Factor 15 (GDF-15) Polypeptides In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 10,537,681 | Injector and Method of Assembly In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 11,160,931 | Method of Assembling and Filling a Drug Delivery Device In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 9,418,416 | Methods and Apparati for Nondestructive Detection of Undissolved Particles in a Fluid In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 9,346,798 | Dihydrobenzoxazine and Tetrahydroquinoxaline Sodium Channel Inhibitors In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 9,408,831 | Methods for Treating Respiratory Viral Infection In force · High confidence | Amgen Inc. | In force | High confidence | |
| 97 more term ends in 2033 · Pro | |||||
10 of 107 patents shown. Soonest term end first, then patent number.
Pro members see all 107.
100 of these are in force and held by Amgen Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.